A Study to Evaluate the Real-world Effectiveness & Usage of Alprolix in

See also
Status	Clinical Trial	Phase
Completed	`NCT03660774` - A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Completed	`NCT02568202` - Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)	N/A
Completed	`NCT01949792` - A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors	Phase 1
Completed	`NCT01562587` - Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State	Phase 1
Completed	`NCT03276130` - Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B
Completed	`NCT01228669` - Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B	Phase 1
Completed	`NCT01988532` - Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia	N/A
Completed	`NCT01234545` - Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors	N/A
Enrolling by invitation	`NCT03690336` - Adverse Event Data Collection From External Registries on Nonacog Beta Pegol
Completed	`NCT02241694` - To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives	N/A
Completed	`NCT01220141` - Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B	N/A
Completed	`NCT01562457` - Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State	Phase 1
Completed	`NCT03055611` - A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B
Active, not recruiting	`NCT05365217` - A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Prevention of Bleedings in Chinese People With Haemophilia B	Phase 3
Completed	`NCT01467427` - Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.	Phase 3
Completed	`NCT03075670` - A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B	Phase 1
Completed	`NCT02300519` - Thrombin Generation Numerical Models Validation in Haemophilic Case	N/A
Withdrawn	`NCT02084810` - Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects	Phase 1
Completed	`NCT02049099` - A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care	N/A
Completed	`NCT01959555` - Project to Update the Study of Congenital Haemophilia in Spain	N/A

NCT number	NCT03655340
Study type	Observational
Source	Swedish Orphan Biovitrum
Contact
Status	Completed
Phase
Start date	September 12, 2018
Completion date	March 16, 2022

A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France — B-SURE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms